Ablynx

Healthcare 📍 Zwijnaarde, Belgium 👥 201-500 employees 💰 $186.0M raised 📅 Founded 2001

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Belgium

Employees

201-500

Total Raised · Grant

$186.0M

Founded

2001

Cloud

Unknown

Email

Mimecast

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Mimecast
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$1M – $3M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Ablynx's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction